Antal Csepregi

773 total citations
27 papers, 506 citations indexed

About

Antal Csepregi is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Antal Csepregi has authored 27 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 11 papers in Epidemiology and 6 papers in Rheumatology. Recurrent topics in Antal Csepregi's work include Liver Disease Diagnosis and Treatment (8 papers), Liver Diseases and Immunity (8 papers) and Liver Disease and Transplantation (4 papers). Antal Csepregi is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Liver Diseases and Immunity (8 papers) and Liver Disease and Transplantation (4 papers). Antal Csepregi collaborates with scholars based in Germany, Hungary and Austria. Antal Csepregi's co-authors include Peter Malfertheiner, Christoph Röcken, Juliane Hoffmann, Hans‐Ulrich Schulz, Péter Szodoray, Margit Zeher, Albert Roessner, Gerhard Treiber, Regine Schneider‐Stock and Fabian Model and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Antal Csepregi

27 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antal Csepregi Germany 13 200 176 153 127 88 27 506
Fang‐Ying Kuo Taiwan 16 255 1.3× 224 1.3× 104 0.7× 205 1.6× 150 1.7× 47 645
M. Guidi Italy 10 310 1.6× 298 1.7× 74 0.5× 96 0.8× 66 0.8× 16 524
N. Peter Libbey United States 7 151 0.8× 72 0.4× 69 0.5× 166 1.3× 76 0.9× 10 413
Peer Flemming Germany 13 303 1.5× 181 1.0× 165 1.1× 277 2.2× 131 1.5× 16 695
Shuichi Terasaki Japan 11 316 1.6× 253 1.4× 47 0.3× 142 1.1× 77 0.9× 23 459
Yukio KUSUMOTO Japan 12 234 1.2× 226 1.3× 69 0.5× 68 0.5× 50 0.6× 36 508
Alexander I. Aspinall Canada 10 396 2.0× 287 1.6× 77 0.5× 173 1.4× 55 0.6× 16 632
Shigeo Maruyama Japan 9 182 0.9× 188 1.1× 46 0.3× 58 0.5× 46 0.5× 25 378
Edward Mena United States 14 364 1.8× 471 2.7× 122 0.8× 123 1.0× 79 0.9× 28 696
Polly W.Y. Lam China 10 74 0.4× 83 0.5× 84 0.5× 127 1.0× 184 2.1× 12 385

Countries citing papers authored by Antal Csepregi

Since Specialization
Citations

This map shows the geographic impact of Antal Csepregi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antal Csepregi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antal Csepregi more than expected).

Fields of papers citing papers by Antal Csepregi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antal Csepregi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antal Csepregi. The network helps show where Antal Csepregi may publish in the future.

Co-authorship network of co-authors of Antal Csepregi

This figure shows the co-authorship network connecting the top 25 collaborators of Antal Csepregi. A scholar is included among the top collaborators of Antal Csepregi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antal Csepregi. Antal Csepregi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schütte, Kerstin, Lars Zimmermann, Jan Bornschein, et al.. (2011). Sorafenib Therapy in Patients with Advanced Hepatocellular Carcinoma in Advanced Liver Cirrhosis. Digestion. 83(4). 275–282. 14 indexed citations
2.
Csepregi, Antal, Matthias PA Ebert, Christoph Röcken, et al.. (2010). Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma. BMC Cancer. 10(1). 317–317. 40 indexed citations
3.
Altorjay, I, Zsuzsanna Vitális, István Tornai, et al.. (2010). Mannose-binding lectin deficiency confers risk for bacterial infections in a large Hungarian cohort of patients with liver cirrhosis. Journal of Hepatology. 53(3). 484–491. 22 indexed citations
4.
Csepregi, Antal, et al.. (2008). p16 protein expression in the liver: an immunohistochemical study. Zeitschrift für Gastroenterologie. 46(1). 1 indexed citations
5.
Bohr, Ulrich, Doerthe Kuester, Frank Meyer, et al.. (2007). Low prevalence of Helicobacteraceae in gall-stone disease and gall-bladder carcinoma in the German population. Clinical Microbiology and Infection. 13(5). 525–531. 29 indexed citations
6.
Csepregi, Antal, Christoph Röcken, Juliane Hoffmann, et al.. (2007). APC promoter methylation and protein expression in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 134(5). 579–589. 42 indexed citations
7.
Csepregi, Antal. (2006). Budesonide induces complete remission in autoimmune hepatitis. World Journal of Gastroenterology. 12(9). 1362–1362. 47 indexed citations
8.
Rickes, Steffen, Gerhard Treiber, Klaus Mönkemüller, et al.. (2006). Impact of the operator's experience on value of high-resolution transabdominal ultrasound in the diagnosis of choledocholithiasis: A prospective comparison using endoscopic retrograde cholangiography as the gold standard. Scandinavian Journal of Gastroenterology. 41(7). 838–843. 30 indexed citations
9.
Ebert, Matthias, Fabian Model, Suzanne Mooney, et al.. (2006). Aristaless-like Homeobox-4 Gene Methylation Is a Potential Marker for Colorectal Adenocarcinomas. Gastroenterology. 131(5). 1418–1430. 98 indexed citations
10.
Treiber, Gerhard, Antal Csepregi, & Peter Malfertheiner. (2005). The Pathophysiology of Portal Hypertension. Digestive Diseases. 23(1). 6–10. 25 indexed citations
11.
Csepregi, Antal. (2005). Acute exacerbation of autoimmune hepatitis induced by Twinrix. World Journal of Gastroenterology. 11(26). 4114–4114. 11 indexed citations
12.
Bı́ró, Adrienn, Anna Horváth, Lilian Varga, et al.. (2003). Serum Anti-cholesterol Antibodies in Chronic Hepatitis-C Patients During IFN-α-2b Treatment. Immunobiology. 207(3). 161–168. 9 indexed citations
13.
Csepregi, Antal, Petra Obermayer–Straub, Susanne Kneip, et al.. (2003). Characterization of a Lipoyl Domain‐Independent B‐Cell Autoepitope on the Human Branched‐Chain Acyltransferase in Primary Biliary Cirrhosis and Overlap Syndrome with Autoimmune Hepatitis. Journal of Immunology Research. 10(2-4). 173–181. 5 indexed citations
14.
Csepregi, Antal, Péter Szodoray, & Margit Zeher. (2002). Do Autoantibodies Predict Autoimmune Liver Disease in Primary Sjögren's Syndrome? Data of 180 Patients upon a 5 Year Follow‐Up. Scandinavian Journal of Immunology. 56(6). 623–629. 31 indexed citations
15.
Csepregi, Antal, et al.. (2001). LKM3 autoantibodies in hepatitis C cirrhosis: a further phenomenon of the HCV-induced autoimmunity. The American Journal of Gastroenterology. 96(3). 910–911. 22 indexed citations
16.
Szodoray, Péter, et al.. (2001). Study of hepatitis C virus infection in 213 Hungarian patients with Sjögren's syndrome. Rheumatology International. 21(1). 6–9. 8 indexed citations
17.
Csepregi, Antal, et al.. (2000). Chronic seropositive polyarthritis associated with hepatitis B virus-induced chronic liver disease: A sequel of virus persistence. Arthritis & Rheumatism. 43(1). 232–238. 10 indexed citations
18.
Csepregi, Antal, et al.. (2000). Effects of interferon treatment on the glucose metabolism of patients with chronic hepatitis C. European Journal of Internal Medicine. 11(3). 151–155. 9 indexed citations
19.
Bíró, Lajos, Lilian Varga, Alajos Pár, et al.. (2000). Changes in the acute phase complement component and IL-6 levels in patients with chronic hepatitis C receiving interferon α-2b. Immunology Letters. 72(2). 69–74. 14 indexed citations
20.
Csepregi, Antal, et al.. (1998). Autoantibodies against 2-oxoacid dehydrogenase complex in primary Sjögren's syndrome: are they early markers of PBC?. Journal of Hepatology. 28. 227–227. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fang‐Ying Kuo Breakdown of academic impact, for papers by M. Guidi Breakdown of academic impact, for papers by N. Peter Libbey Breakdown of academic impact, for papers by Peer Flemming Breakdown of academic impact, for papers by Shuichi Terasaki Breakdown of academic impact, for papers by Yukio KUSUMOTO Breakdown of academic impact, for papers by Alexander I. Aspinall Breakdown of academic impact, for papers by Shigeo Maruyama Breakdown of academic impact, for papers by Edward Mena Breakdown of academic impact, for papers by Polly W.Y. Lam
Rankless by CCL
2026